Nutraq as · 99-39 · NORWAY
For Nutraq as, import alert is 99-39; country is NORWAY; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; product is ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C; product code is 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 05/05/2015; address is Enebakkveien 117 , Oslo, NO-03 NORWAY, verified against its source on 2026-09-30.
- Firm
- Nutraq as verified
- Import alert
- 99-39
- Import alert name
- Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- Country
- NORWAY verified
- Address
- Enebakkveien 117 , Oslo, NO-03 NORWAY verified
- Date published
- 05/05/2015 verified
- Product code
- 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 46 Y - - 99 Food Additives For Human Use, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 A - - 99 Vitamin, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. each item verified
- Product
- ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C | ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan | nbg 24 7 Dietary Supplement W/ Vit. C each item verified
- FDA notes
- The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 | The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 each item verified
What the source says
Nutraq as Date Published : 05/05/2015 Enebakkveien 117 , Oslo, NO-03 NORWAY
— accessdata.fda.gov, retrieved 2026-09-22
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 46 Y - - 99 Food Additives For Human Use, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 46 Y - - 99 Food Additives For Human Use, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 A - - 99 Vitamin, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 A - - 99 Vitamin, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 05/05/2015 Desc: ImmunoPlus/ Immunoplus Dietary Supplement W/ Norwegian Betaglucan Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 05/05/2015 Desc: nbg 24 7 Dietary Supplement W/ Vit. C Notes: The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of Section 403 (y) of the Act [21 U.S.C. 343(y)] in that each label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such a dietary supplement. The articles are subject to refusal of admission pursuant to section 801(1)(3) in that they appear to be misbranded within the meaning of section 403(f) of the Act [21 U.S.C. 343 (f)] because each product label contains information in two languages, but does not repeat all of the required information in both languages; The articles are subject to refusal of admission pursuant to section 801(a) (3) in that they appear to be misbranded within the meaning of section 403 (q)(5)(F) of the Act [21 U.S.C. 343(q)(5)(F)] in that each product label fails to include a supplement facts panel as required by 21 CFR 101.36. Published on 05/05/2015
— all from accessdata.fda.gov, retrieved 2026-09-22
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1144.html